Press Releases

CRN Foundation’s Economic Report Outlines Value of Lutein and Zeaxanthin in Reducing Medical Costs Associated with Age-Related Macular Degeneration

The CRN Foundation’s recent Health Care Cost Savings report, Supplement to Savings (“S2S”), identified up to $106.6 million in net savings if lutein and zeaxanthin are used by the at-risk target populations most susceptible to AMD.

FDA ‘Healthy’ Claim Proposal Should Include Supplements and Functional Foods, says CRN

CRN today submitted comments to FDA on its proposed rule updating the “healthy” implied nutrient content claim. CRN’s comments to FDA emphasized the value of including dietary supplements and functional foods in the final rule and urged the agency to reconsider its “food groups-only” approach.

Trade Associations Commend Senators Lee and Sinema for Highlighting Dietary Supplements and Establishing Natural Products Industry Week

Today the American Herbal Products Association (AHPA), the Consumer Healthcare Products Association (CHPA), the Council for Responsible Nutrition (CRN), and the United Natural Products Alliance (UNPA), organizations representing dietary supplement manufacturers, marketers, and ingredient suppliers, released the below statements commending Senators Lee (R-UT) and Sinema (I-AZ) on their Resolution recognizing the importance of dietary supplements and highlighting the natural products industry’s contributions to America’s health and economy.

CRN-I Invites Government, Academic, and Industry Stakeholders to Science-based Policy Symposium in Conjunction with Codex Meeting 

The Council for Responsible Nutrition-International (CRN-I), the international arm of the U.S.-based Council for Responsible Nutrition (CRN), will hold an in-person symposium on March 5 in in Düsseldorf, Germany, prior to the Codex Committee on Nutrition and Foods for Special Dietary Uses (CCNFSDU) meeting.

FDA Response on CBD Fails Consumers and Industry and Highlights Agency’s Four Years of Inaction

CRN expressed dismay today about FDA’s denial of its 2020 citizen petition calling on the agency to create a regulatory pathway to legally market dietary supplements containing hemp-derived cannabidiol (CBD) and the agency’s separate announcement that FDA “has concluded a new regulatory pathway for CBD is needed that balances individuals’ desire for access to CBD products with the regulatory oversight needed to manage risks.”

CRN Foundation’s Economic Report Shows the Potential of Certain Dietary Supplements To Reduce Medical Costs Associated with Coronary Artery Disease

Observance of February as Heart Month can be a reminder of the cost-saving potential of evidence-backed dietary supplements to help reduce the health impacts—and the healthcare costs—of coronary artery disease. The CRN Foundation’s recent Health Care Cost Savings report, Supplement to Savings (“S2S”), identified up to $17.74 billion in annual net savings if specific dietary supplements (omega-3 fatty acids, magnesium, vitamin K2 and soluble fiber) are used by the at-risk target populations most susceptible to coronary artery disease (CAD). The study, commissioned by the CRN Foundation and conducted by Frost & Sullivan, provides analysis on the risk reduction effects supplementation can have on specific chronic illnesses or diseases, including CAD. The Foundation announced the overall findings including insights on the analysis in August 2022.